THE Manufacturers Life Insurance Co. (Phils.) Inc., the local arm of international financial services provider Manulife Financial Corp., announced it will offer gut microbiome screening in the local market through a partnership with Singapore-based Amili Pte. Ltd.,.
Microbiome testing analyzes a stool sample to reveal the types of microorganisms in a person’s gut, such as bacteria, fungi and viruses. The test could be linked to one’s digestion health, immunity and overall health.
Amili, also known as ‘Asian Microbiome Library,’ will offer science-backed, preventive care that supports better health outcomes and reduces long-term medical risks, the company said.
‘At Manulife Philippines, we are focused on delivering innovative solutions that support the evolving health needs of Filipinos,’ Manulife President and CEO Rahul Hora said.
‘This collaboration with AMILI allows us to offer a unique health experience that goes beyond traditional insurance, empowering our customers to take a proactive approach to their health,’ Hora added.
Manulife’s customers in the Philippines will now be able to access a personalized gut-health screening designed specifically for the Asian population. The service includes tailored nutrition recommendations and teleconsultation to help interpret results, the company added.
‘Our goal is to be a true partner in our customers’ health journey-not just by helping them prepare financially, but also by giving them access to tools, services, and support for prevention, care, and overall well-being,’ Grace M. Mallabo, chief health and product officer of Manulife Philippines, said.
‘By integrating personalized health insights into our offerings, we are helping Filipinos make informed decisions and improve their quality of life,’ Mallabo added.
According to Manulife, Amili’s screening leverages the region’s largest multi-ethnic gut microbiome database, delivering insights that support digestive health, immunity, mental well-being, and chronic disease prevention.
‘We’re proud to support Manulife’s customers in the Philippines with actionable, science-backed health insights,’ Jeremy Lim, CEO and co-founder of Amili, said. ‘This partnership is a step forward in making predictive, preventive care more accessible across Southeast Asia.’
This initiative in the Philippines is an expansion of the collaboration between Manulife and Amili, which was launched last year in Singapore. It is part of Manulife’s broader strategy to support health and longevity through value-added offerings across Asia, according to the insurer.